![]() Press Release Distribution |
Filter News Show All ResultsNews By Country None FoundNews By Tag Enz ![]() Related Tags American Video Teleconferencing
Avot.pk Biomedical Biotechnology Canada CLNO Crown Equity Holdings Crwe Crwe.ob Diagnostics Digital Advertising Digital Media Enzo Enzo Biochem Exploration Genetic Process Life Sciences Nyse:enz Power3 Medical Products Pwrm
| enz Latest News+ XML/RSSBy Karl McMahon FormFactor Inc. (Nasdaq:FORM) will report financial results for its 2010 fourth quarter on Tuesday, February 1, 2011, at 1:30 p.m. Pacific Standard Time. By Karl McMahon Alexander's Inc. (NYSE:ALX) announced that its Board of Directors has declared an increased quarterly dividend of $3.00 per share (a new indicated annual rate of $12.00). By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Karl McMahon American Video Teleconferencing Corp. (Pink Sheets:AVOT) is pleased to announce that it has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Derrick Bosket Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services. By Lynn Lumpkin Enzo Biochem, Inc. (NYSE:ENZ) reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Karl McMahon American Video Teleconferencing Corp. (Pink Sheets:AVOT) is presently in final discussions to enter into a formal agreement to acquire an exclusive option on a molybdenum property in the Otter lake area in the province of Quebec, Canada. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. By Karl McMahon Enzo Biochem, Inc. (NYSE:ENZ) reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations. By Shareholders Foundation, Inc. Investigation on behalf of current investors of Enzo Biochem, Inc. (NYSE:ENZ) over breaches of fiduciary duty – ENZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com | ||||||||||||||||||||||